# CorWave

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/corwave

- Industry: Medical Devices & Equipment
- Headquarters: Paris, France
- Website: www.corwave.fr
- Total disclosed funding: $99M
- Latest round: Series C (Jun 20, 2023)
- Investors on record: 10

## About

CorWave SA is a medical technology company focused on developing advanced implantable blood pumps that improve cardiac assistance solutions for patients with heart failure.Founded in 2012 and headquartered in Paris, France, CorWave SA specializes in innovative medical devices for cardiac support. The company has raised EUR 61.00 mn in Series C funding recently on June 20, 2023, with investments from Exor Ventures, Vlerick Group, and Bpifrance. CEO Louis de Lillers leads the firm, which has secured a total of 5 deals since inception.CorWave specializes in the development of innovative implantable blood pumps, primarily utilizing their proprietary wave membrane technology. Their flagship product, the Left Ventricular Assist Device (LVAD), supports patients with advanced heart failure by ensuring pulsatile blood flow, simulating a natural heartbeat. The company targets healthcare providers and hospitals in advanced markets such as Europe and North America, focusing on improving patient outcomes with its advanced cardiac devices.For the most recent year, CorWave reported zero revenue. The EBITDA for 2023 stood at EUR -1,362,020.60, reflecting ongoing investments in development and market positioning.In June 2023, CorWave raised EUR 61 mn in Series C funding to finance its development. The company aims to enhance its product lineup and expand into new geographic markets, including further penetration in Europe and North America. Specific timelines for product launches and market entries will be aligned with their ongoing development efforts.

## Funding rounds

- Series C, Jun 20, 2023, $66M — Bpifrance, Vlerick Group, Exor Ventures
- Series C, Jan 6, 2021, $19M — Sofinnova Partners, Seventure Partners, Ysios Capital Partners, Bpifrance, Novo Holdings, Montpensier Arbevel, European Innovation Council, M&L Healthcare
- Series B, Feb 9, 2017, $8.8M — Sofinnova Partners, Seventure Partners, Ysios Capital Partners, Bpifrance, Novo Holdings
- Series A, Apr 23, 2014, $4.7M — Sofinnova Partners, Seventure Partners, Bpifrance

## Investors

- Sofinnova Partners (https://capitalatlas.ai/funds/sofinnova-partners) — Series A, Series B, Series C
- Seventure Partners (https://capitalatlas.ai/funds/seventure-partners) — Series A, Series B, Series C
- Bpifrance — Series A, Series B, Series C
- Ysios Capital Partners (https://capitalatlas.ai/funds/ysios-capital-partners) — Series B, Series C
- Novo Holdings — Series B, Series C
- Montpensier Arbevel (https://capitalatlas.ai/funds/montpensier-arbevel) — Series C
- European Innovation Council (https://capitalatlas.ai/funds/european-innovation-council) — Series C
- M&L Healthcare — Series C
- Vlerick Group — Series C
- Exor Ventures — Series C